There shall be no changes to this Agreement unless amended or modified in writing by the Company
Just this month, on January 29, 2026, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) issued an important update for patients and prescribers
Oral Semaglutide Induces Loss of Body Fat Mass Without Affecting Muscle Mass in Patients With Type 2 Diabetes
Aim for clinics offering FDA-approved medications, as these provide superior efficacy and safety compared to compounded alternatives
The pricing reflects Janoshik testing costs, 99% HPLC purity manufacturing, SPPS synthesis of a 39-amino-acid triple-agonist peptide, domestic Canadian stocking, same-day dispatch, and Canada Post Xpresspost shipping
If you're wondering whether a GLP-1 might be right for you, your Nice Healthcare clinician is here to help